The precise brain mechanisms that enable animals to overcome instinctive fears have been unveiled by researchers at the Sainsbury Wellcome Centre at UCL.
Published today in Science, the study in mice could have implications for developing therapeutics for fear-related disorders such as phobias, anxiety and post-traumatic stress disorder (PTSD).
The research team, led by Dr Sara Mederos and Professor Sonja Hofer, mapped out how the brain learns to suppress responses to perceived threats that prove harmless over time.
Co-lead author Dr Mederos, Research Fellow in the Hofer Lab at the Sainsbury Wellcome Center at UCL, said: "Humans are born with instinctive fear reactions, such as responses to loud noises or fast-approaching objects. However, we can override these instinctive responses through experience - like children learning to enjoy fireworks rather than fear their loud bangs. We wanted to understand the brain mechanisms that underlie such forms of learning."
Using an innovative experimental approach, the team studied mice presented with an overhead expanding shadow that mimicked an approaching aerial predator. Initially, the mice sought shelter when encountering this visual threat. However, with repeated exposure and no actual danger, the mice learned to remain calm instead of escaping, providing researchers with a model to study the suppression of fear responses.
Based on previous work in the Hofer Lab, the team knew that an area of the brain called the ventrolateral geniculate nucleus (vLGN) could suppress fear reactions when active and was able to track knowledge of previous experience of threat. The vLGN also receives strong input from visual areas in the cerebral cortex, and so the researchers explored whether this neural pathway had a role in learning not to fear a visual threat.
The study revealed two key components in this learning process: specific regions of the visual cortex in the brain proved essential for the learning process, and the vLGN brain structure stores these learning-induced memories.
Dr Mederos explained: "We found that animals failed to learn to suppress their fear responses when specific cortical visual areas where inactivated. However, once the animals had already learned to stop escaping, the cerebral cortex was no longer necessary."
Senior author Professor Hofer said: "Our results challenge traditional views about learning and memory. While the cerebral cortex has long been considered the brain's primary centre for learning, memory and behavioural flexibility, we found the subcortical vLGN and not the visual cortex actually stores these crucial memories. This neural pathway can provide a link between cognitive neocortical processes and 'hard-wired' brainstem-mediated behaviours, enabling animals to adapt instinctive behaviours."
The researchers also uncovered the cellular and molecular mechanisms behind this process. Learning occurs through increased neural activity in specific vLGN neurons, triggered by the release of endocannabinoids - brain-internal messenger molecules known to regulate mood and memory. This release decreases inhibitory input to vLGN neurons (brain cells), resulting in heightened activity in this brain area when the visual threat stimulus is encountered, which suppresses fear responses.
The implications of this discovery extend beyond the laboratory.
Professor Hofer explained: "Our findings could also help advance our understanding of what is going wrong in the brain when fear response regulation is impaired in conditions such as phobias, anxiety and PTSD. While instinctive fear reactions to predators may be less relevant for modern humans, the brain pathway we discovered exists in humans too.
"This could open new avenues for treating fear disorders by targeting vLGN circuits or localised endocannabinoid systems."
The research team is now planning to collaborate with clinical researchers to study these brain circuits in humans, with the hope of someday developing new, targeted treatments for maladaptive fear responses and anxiety disorders.
This research was supported by the Gatsby Charity Foundation, Wellcome and EMBO.
